The vaccinia virus G3L/WR079 gene encodes a conserved protein with a predicted transmembrane domain. Our proteomic analyses of vaccinia virus revealed that G3L protein is incorporated into intracellular mature virus; however, the function of G3L protein in the vaccinia virus life cycle has not been investigated. In this study, a recombinant vaccinia virus, viG3L, expressing G3L protein under IPTG (isopropyl--D-thiogalactopyranoside) regulation was constructed. Under permissive conditions when G3L protein was expressed, the vaccinia virus life cycle proceeded normally, resulting in plaque formation in BSC40 cells. In contrast, under nonpermissive conditions when G3L protein expression was repressed, no plaques were formed, showing that G3L protein is essential for vaccinia virus growth in cell cultures. In infected cells when G3L protein was not expressed, the formation of intracellular mature virus (IMV) and cell-associated enveloped virus occurred normally, showing that G3L protein is not required for virion morphogenesis. IMV particles containing (G3L ؉ ) or lacking (G3L ؊ ) G3L protein were purified and were found to be indistinguishable on microscopic examination. Both G3L ؉ and G3L ؊ IMV bound to HeLa cells; however, G3L ؊ IMV failed to enter the cells, showing that G3L protein is required for IMV penetration into cells. Finally, G3L protein was required for fusion of the infected cells under low-pH treatment. Thus, our results provide direct evidence that G3L is an essential component of the vaccinia virus fusion complex, in addition to the previously reported A28, H2, L5, A21, and A16 proteins.Vaccinia virus, the prototype of the orthopoxvirus genus of the family Poxviridae, infects many cell lines and animals (9) and produces several forms of infectious particles, namely, intracellular mature virus (IMV), intracellular enveloped virus (IEV), cell-associated enveloped virus (CEV), and extracellular enveloped virus (EEV) (25). The membrane structure of IMV is different from that of IEV, which, again, is different from that of CEV and EEV (40). Although IMV and EEV were originally shown to enter cells through different mechanisms (22,35,39), recent studies have revealed that a conserved viral fusion complex is required for the penetration of both viruses (26,27,31,32,37,38). Although no cellular coreceptor has been identified for vaccinia virus, some data suggest that cell-bound IMV initiates plasma membrane fusion to deliver viral cores into cells (1,2,8,22,39). In addition, IMV entry has been shown to trigger cell signaling pathways that involve Rac, MEK, extracellular signal-regulated kinase, protein kinase A, and protein kinase C activation, but the molecular mechanism is unknown (7,20,22).IMV represents the majority of the infectious progeny produced in cells, and our recent proteomic study revealed that it contains 75 viral proteins (4). Of these, nine have been shown to play a role in vaccinia virus entry (see below). The viral envelope proteins, H3L and A27L, bind to heparan sulfates, whereas D8L b...